For the first time, we demonstrate that GILZ, by interacting with STAT5, functions as an anti-inflammatory agent by reducing neutrophil activity, with a consequent reduction in pathogen recognition and potential major risk of exposure to pathogen-derived infection. This evidence concerns the gene TSC22D3 and infection.